| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |